Athira Pharma's IPO expected to raise $204M

It would be the first Seattle biotech IPO since Adaptive Biotechnologies' $345 million IPO in June 2019.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.